Application of cell engineering technology to the tumour immunotherapeutic drug: A review

被引：6

作者：

Chen, ZN ^{[1
]}

Xing, JL ^{[1
]}

Bian, HJ ^{[1
]}

Mi, L ^{[1
]}

Jiang, JL ^{[1
]}

机构：

[1] Fourth Mil Med Univ, Cell Engn Res Ctr, Xian 710032, Peoples R China

来源：

CELL BIOLOGY INTERNATIONAL | 2001年 / 25卷 / 10期

关键词：

cell engineering technology; tumour; immunotherapeutic drugs;

D O I：

10.1006/cbir.2001.0753

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The concept of cell engineering is frequently mentioned in recent years. It's a comprehensive technology which is very powerful and useful. By using it, scientists can produce many kinds of proteins and other biological moleculars in large scale that are in great demand for the human being. Among these products, most can be used for tumour immunotherapy and have been confirmed to be very effective in tumour control or subsidiary treatment. Of them, most common and useful drugs include three sorts; tumour vaccines, cell factors and monoclonal antibodies. The paper will discuss in detail related drugs application advances in tumour immunotherapy. (C) 2001 Academic Press.

引用

页码：1013 / 1015

页数：3

共 7 条

[1]

Chen ZN, 1999, J CELL MOL IMMUNOL, V15, P34

[2] INTERFERONS IN HUMAN PAPILLOMAVIRUS INFECTIONS [J].

CIRELLI, R ;

TYRING, SK .

ANTIVIRAL RESEARCH, 1994, 24 (2-3) :191-204

[3] THROMBOPOIETIC EFFECTS AND TOXICITY OF INTERLEUKIN-6 IN PATIENTS WITH OVARIAN-CANCER BEFORE AND AFTER CHEMOTHERAPY - A MULTICENTRIC PLACEBO-CONTROLLED, RANDOMIZED PHASE IB STUDY [J].

DHONDT, V ;

HUMBLET, Y ;

GUILLAUME, T ;

BAATOUT, S ;

CHATELAIN, C ;

BERLIERE, M ;

LONGUEVILLE, J ;

FEYENS, AM ;

DEGREVE, J ;

VANOOSTEROM, A ;

VONGRAFFENRIED, B ;

DONNEZ, J ;

SYMANN, M .

BLOOD, 1995, 85 (09) :2347-2353

[4]

JURCIC JG, 1995, CANCER RES, V55, pS5908

[5] Iodine-131 - Anti-B1 radioimmunotherapy for B-cell lymphoma [J].

Kaminski, MS ;

Zasadny, KR ;

Francis, IR ;

Fenner, MC ;

Ross, CW ;

Milik, AW ;

Estes, J ;

Tuck, M ;

Regan, D ;

Fisher, S ;

Glenn, SD ;

Wahl, RL .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (07) :1974-1981

[6] Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: Implications for a clinically relevant tumor vaccine [J].

Mahvi, DM ;

Burkholder, JK ;

Turner, J ;

Culp, J ;

Malter, JS ;

Sondel, PM ;

Yang, NS .

HUMAN GENE THERAPY, 1996, 7 (13) :1535-1543

[7] Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: Implications for autologous vaccine production [J].

Tung, C ;

Federoff, HJ ;

Brownlee, M ;

Karpoff, H ;

Weigel, T ;

Brennan, MF ;

Fong, Y .

HUMAN GENE THERAPY, 1996, 7 (18) :2217-2224

← 1 →